Metabolism - Clinical and Experimental
Volume 54, Issue 5, Supplement , Pages 24-27 , May 2005

Neurobiological basis of depression: an update

  • Madhu Kalia

      Affiliations

    • Corresponding Author InformationTel.: +1 215 920 5134; fax: +1 610 687 8506.

References 

  1. Murray CJ, Lopez AD. Evidence-based health policy—lessons from the Global Burden of Disease Study. Science. 1996;274:740–743
  2. US Department of Health and Human Services. Mental Health: a report of the surgeon general. Rockville (Md): DHHS, USPHS; 1999;
  3. Kapur W, Mieczkowski T, Mann JJ. Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA. 1992;268:3441–3445
  4. Akiskal HS. Interaction of biologic and psychologic factors in the origin of depressive disorders. Acta Physiol Scand. 1985;319(Suppl.):131–139
  5. Keller MB, Shapiro RW. “Double depression”: superimposition of acute depressive episodes on chronic depressive disorders. Am J Psychiatry. 1982;139:438–442
  6. Goodwin F, Jamison K. Manic-depressive illness. New York: Oxford University Press; 1990;
  7. Howland RH, Thase ME. A comprehensive review of cyclothymic disorder. J Nerv Ment Dis. 1993;181:485–493
  8. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influences of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–389
  9. Hall D. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet. 2003;73:370
  10. Hariri AR, Mattay VS, Tessiyore A, Kolachana B, Fera F, Goldman D, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002;297:400–403
  11. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampus function. Cell. 2003;112:257–269
  12. Pryor JC, Sulser F. Evolution of the monoamine hypothesis of depression. In:  Horton RW,  Katona CLE editor. Biological aspects of affective disorders. New York: Academic Press; 1991;p. 77–94
  13. Freis ED. Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N Engl J Med. 1954;251:1006–1008
  14. Coppen A, Wood K. Five-hydroxytryptamine in the pathogenesis of affective disorders. Adv Biochem Psychopharmacol. 1982;34:249–258
  15. Murphy DL, Campbell L, Costa JL. In:  Lipton MA,  DiMascio A,  Killam KF editor. Psychopharmacology: A generation of progress. New York: Raven Press; 1978;p. 1235–1247
  16. Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?. Arch Gen Psychiatry. 1976;33:1193–1197
  17. Brown GL, Goodwin FK, Ballenger JC, et al. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979;1:131–139
  18. Meltzer HY, Lowy MT. In:  Meltzer HY editors. Psychopharmacology: the third generation of progress. New York: Raven Press; 1987;p. 513–526
  19. van Praag HM, de Hann S. Chemoprophylaxis of depression: an attempt to compare lithium with 5-hydroxytryptophan. Acta Psychiatr Scand. 1981;63(Suppl. 290):191–205
  20. Vetulani J, Sulser F. Actions of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature. 1975;275:495–496
  21. Hartig PR. Molecular pharmacology of serotonin receptors. EXS. 1994;71:93–102
  22. Siggins GR, Schultz JE. Chronic treatment with lithium or desimpramine alters discharge frequency and norepinephrine responsiveness of cerebellar Purkinje cells. Proc Natl Acad Sci U S A. 1979;6:5987–5991
  23. de Montigny C, Aghajanian GK. Tricyclic antidepressants, long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science. 1978;202:1303–1306
  24. Paykel ES. Depression: clinical aspects. Br J Psychiatry. 1979;134:211–213
  25. Akiskal HS. Interaction of biologic and psychologic factors in the origin of depression disorders. Acta Psychiatr Scand. 1985;319(Suppl.):131–139
  26. McEwen BE. Glucocorticoids, depression, mood disorders: structural remodeling in the brain. Metabolism. 2005;54(Suppl.):20–23

PII: S0026-0495(05)00031-4

doi: 10.1016/j.metabol.2005.01.009

Metabolism - Clinical and Experimental
Volume 54, Issue 5, Supplement , Pages 24-27 , May 2005

Article Tools